尿中2,5-ヘキサンジオン(HD)のバックグランド値および作業者尿中HD濃度におよぼす加水分解条件の影響
暂无分享,去创建一个
T. Sakai | Y. Takeuchi | Y. Ikeya | T. Araki | K. Ushio
[1] H. Bolt,et al. The relevance of 4,5-dihydroxy-2-hexanone in the excretion kinetics ofn-hexane metabolites in rat and man , 1987, Archives of Toxicology.
[2] N. Hisanaga,et al. Determination of urinary 2,5-hexanedione concentration by an improved analytical method as an index of exposure to n-hexane. , 1991, British journal of industrial medicine.
[3] M. Ogata,et al. Urinary 2,5-hexanedione assay involving its conversion to 2,5-dimethylpyrrole , 1991, International archives of occupational and environmental health.
[4] T. Kawai,et al. 2-Acetylfuran, a confounder in urinalysis for 2,5-hexanedione as an n-hexane exposure indicator , 1991, International archives of occupational and environmental health.
[5] M. Ikeda,et al. The method of choice for the determination of 2,5-hexanedione as an indicator of occupational exposure to n-hexane , 1990, International archives of occupational and environmental health.
[6] L. Perbellini,et al. An improved method of analysing 2,5-hexanedione in urine. , 1990, British journal of industrial medicine.
[7] H. Bolt,et al. Detection of 2,5-hexanedione in the urine of persons not exposed to n-hexane , 1986, International archives of occupational and environmental health.
[8] N. Hisanaga,et al. A study on biological monitoring of n-Hexane exposure , 1983, International archives of occupational and environmental health.
[9] P. Spencer,et al. Ultrastructural studies of the dying-back process. V. Axonal neurofilaments accumulate at sites of 2,5-hexanedione application: Evidence for nerve fibre dysfunction in experimental hexacarbon neuropathy , 1980, Journal of neurocytology.
[10] L. Perbellini,et al. Identification of the metabolites of n-hexane, cyclohexane, and their isomers in men's urine. , 1980, Toxicology and applied pharmacology.
[11] G. Waylonis,et al. Polyneuropathy due to n-hexane. , 1976, Archives of internal medicine.
[12] P. Spencer,et al. Nervous system dying-back disease produced by 2,5-hexanedione. , 1975, Transactions of the American Neurological Association.